Analysts’ Opinions Are Mixed on These Healthcare Stocks: Addus Homecare Corp. (NASDAQ: ADUS), OvaScience (NASDAQ: OVAS) and Healthways (NASDAQ: HWAY)

By Austin Angelo

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Addus Homecare Corp. (NASDAQ: ADUS), OvaScience (NASDAQ: OVAS) and Healthways (NASDAQ: HWAY).

Addus Homecare Corp. (NASDAQ: ADUS)

In a report released yesterday, Michael Wiederhorn from Oppenheimer assigned a Buy rating to Addus Homecare Corp. (NASDAQ: ADUS), with a price target of $30. The company’s shares closed yesterday at $26, close to its 52-week high of $27.43.

According to TipRanks.com, Wiederhorn is a top 25 analyst with an average return of 14.7% and a 64.5% success rate. Wiederhorn covers the Healthcare sector, focusing on stocks such as Envision Healthcare, Genesis Healthcare, and Community Health.

Addus Homecare Corp. has an analyst consensus of Moderate Buy, with a price target consensus of $30.

OvaScience (NASDAQ: OVAS)

In a report released yesterday, Rohit Vanjani from Oppenheimer assigned a Hold rating to OvaScience (NASDAQ: OVAS). The company’s shares closed yesterday at $3.73, close to its 52-week low of $3.62.

According to TipRanks.com, Vanjani is a 4-star analyst with an average return of 6.3% and a 49.1% success rate. Vanjani covers the Healthcare sector, focusing on stocks such as Zynerba Pharmaceuticals, ANI Pharmaceuticals, and Endo International.

OvaScience has an analyst consensus of Hold, with a price target consensus of $4.

Healthways (NASDAQ: HWAY)

In a report released yesterday, Mohan Naidu from Oppenheimer assigned a Buy rating to Healthways (NASDAQ: HWAY), with a price target of $27. The company’s shares closed yesterday at $19.90.

According to TipRanks.com, Naidu is a 2-star analyst with an average return of -0.4% and a 45.0% success rate. Naidu covers the Technology sector, focusing on stocks such as Quality Systems, Athenahealth, and Cerner Corp.

Healthways has an analyst consensus of Moderate Buy, with a price target consensus of $27.63.